Results 281 to 290 of about 1,043,746 (362)

Epitranscriptomic modifications in plant RNAs. [PDF]

RNA Biol
Bhat SS, Paul M, Gregory BD.
europepmc   +1 more source

A quantitative cytochemical investigation of DNA, RNA and protein in lymphoid cells from normal, preleukemic and leukemic mice

, 1966
Gösta Gahrton, W Habicht, Britta Wahrén   +2 more
openalex   +1 more source

THE SELECTIVE INTERRUPTION OF NUCLEOLAR RNA SYNTHESIS IN HELA CELLS BY CORDYCEPIN [PDF]

, 1969
Moshe Siev, Robert A. Weinberg, Sheldon Penman   +2 more
openalex   +1 more source

Comparative single‐cell transcriptomic profiling of patient‐derived renal carcinoma cells in cellular and animal models of kidney cancer

FEBS Open Bio, EarlyView.
We generated and characterized clear cell renal cell carcinoma models using the patient‐derived RCC243 cell line—including cell culture, orthotopic, and metastatic tumors—via single‐cell RNA‐sequencing for comparisons between models and patient tumor datasets.
Richard Huang, Lynn Kee, Alexander Gont, Jalna Meens, Fraser G. Ferens, Meredith S. Irwin, Laurie Ailles, Scott A. Yuzwa, Claire M. Robinson, Michael Ohh   +9 more
wiley   +1 more source

Efficient delivery of small RNAs to podocytes in vitro by direct exosome transfection. [PDF]

J Nanobiotechnology
Lange T, Maron L, Weber C, Biedenweg D, Schlüter R, Endlich N.   +5 more
europepmc   +1 more source

Ribonucleic Acid (RNA) Synthesis in Dissociated Embryonic Cells of Xenopus Laevis.

, 1966
Kiyotaka Yamana, Koichiro Shiokawa
openalex   +2 more sources

METTL3 knockout accelerates hepatocarcinogenesis via inhibiting endoplasmic reticulum stress response

FEBS Open Bio, EarlyView.
Liver‐specific knockout of N6‐methyladenosine (m6A) methyltransferase METTL3 significantly accelerated hepatic tumor initiation under various oncogenic challenges, contrary to the previously reported oncogenic role of METTL3 in liver cancer cell lines or xenograft models. Mechanistically, METTL3 deficiency reduced m6A deposition on Manf transcripts and
Bo Cui, Silin Tu, Haibo Li, Zhancheng Zeng, Ruiqi Xiao, Jing Guo, Xiaoqi Liang, Chang Liu, Lijie Pan, Wenjie Chen, Mian Ge, Xiaofen Zhong, Linsen Ye, Huaxin Chen, Qi Zhang, Yan Xu   +15 more
wiley   +1 more source

A divide-and-conquer approach based on deep learning for long RNA secondary structure prediction: Focus on pseudoknots identification. [PDF]

PLoS One
Omnes L, Angel E, Bartet P, Radvanyi F, Tahi F.   +4 more
europepmc   +1 more source

Adenosine A3 receptor antagonists as anti‐tumor treatment in human prostate cancer: an in vitro study

FEBS Open Bio, EarlyView.
The A3 adenosine receptors (A3ARs) are overexpressed in prostate cancer. AR 292 and AR 357, as A3AR antagonists, are capable of blocking proliferation, modulating the expression of drug transporter genes involved in chemoresistance, ferroptosis, and the hypoxia response, and inducing cell death.
Maria Beatrice Morelli, Andrea Spinaci, Cui Chang, Rosaria Volpini, Catia Lambertucci, Matteo Landriscina, Vincenza Conteduca, Consuelo Amantini, Cristina Aguzzi, Laura Zeppa, Martina Giangrossi, Laura Soverchia, Matteo Santoni, Massimo Nabissi, Giorgio Santoni, Carlo Polidori   +15 more
wiley   +1 more source

RNA therapeutics

RNA Biology, 2023
openaire   +4 more sources